Evidence map›Paper›PMID 42649259›Full record

ArticleNature medicine2026

Publisher Correction: Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

Luca Paruzzo, Emeline R Chong, Elise A Chong, Zhixuan Zheng, Puneeth Guruprasad, Daniel J Landsburg, Sunita D Nasta, Federico Stella, Ranjani Ramasubramanian, Vitor B de Souza and 27 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors.

Luca ParuzzoLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6505-0194
Emeline R ChongLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-0324-5367
Elise A ChongLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-8895-1625
Zhixuan ZhengCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0002-6756-6052
Puneeth GuruprasadCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Daniel J LandsburgLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-5077-4181
Sunita D NastaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Federico StellaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-3401-1309
Ranjani RamasubramanianCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Vitor B de SouzaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0003-2370-9856
Mohannad H AlkhatibDepartment of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Matthew HoCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Antonio ImparatoCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Gregory M ChenCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Don L SiegelCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-2098-2251
Gabriela PlesaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-4279-5943
Anlan DaiCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Shane MackeyCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Priyamvada DasCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Peter MichenerCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Julie JadlowskyCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0005-5115-1321
Frederic D BushmanDepartment of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-4740-4056
Vrutti PatelCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Alberto CarturanLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Ellen B NapierLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Vanessa E GonzalezCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Danuta JarochaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Rong XuCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-8571-3218
Bruce L LevineCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-6971-8465
Patrizia PorazziCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Noelle FreyDepartment of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
David L PorterDepartment of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Jakub SvobodaLymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
Joseph A FraiettaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Carl H JuneCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0241-3557
Stephen J Schuster *Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. stephen.schuster@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-3376-8978
Marco Ruella *Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.ORCID http://orcid.org/0000-0003-4301-5811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42649259
PMCPMC13577896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.